Inventor · disambiguated record
Kristen Pierce
Also filed as: PIERCE KRISTEN
4 granted patents·10 pending applications·5 citations·filing 2004–2025
65Inventor score
Files withFIVE PRIME THERAPEUTICS INC9BHAWE KAUMUDI1FIVE PRIME THERAPETUTICS INC1HESTIR KEVIN1PIERCE KRISTEN1
Top patents by PatentIndex Score
14 records- 0184US10172937B2Method of treatment of malignant solid tumors with afucosylated anti-FGFR2IIIb antibodiesFIVE PRIME THERAPEUTICS INC·Filed 2016·Granted Jan 8, 2019·5 cites·32 claims
- 0275US12465636B2Method of making afucosylated anti-FGFR2IIIB antibodiesFIVE PRIME THERAPEUTICS INC·Filed 2021·Granted Nov 11, 2025·0 cites·13 claims
- 0369US2023052212A1Fgfr2 inhibitors alone or in combination with immune stimulating agents in cancer treatmentFIVE PRIME THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0469US2025269016A1Afucosylated Anti-FGFR2IIIB AntibodiesFIVE PRIME THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0566US11235059B2Afucosylated anti-FGFR2IIIB antibodiesFIVE PRIME THERAPEUTICS INC·Filed 2018·Granted Feb 1, 2022·0 cites·59 claims
- 0665US2025223367A1Fgfr2 inhibitors alone or in combination with immune stimulating agents in cancer treatmentFIVE PRIME THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0759US2015050273A1Afucosylated anti-fgfr2iiib antibodiesFIVE PRIME THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 0856US11447553B2FGFR2 inhibitors alone or in combination with immune stimulating agents in cancer treatmentFIVE PRIME THERAPEUTICS INC·Filed 2016·Granted Sep 20, 2022·0 cites·10 claims
- 0947US2007248605A1Fibroblast Growth Factor Receptors 1,2,3, and 4 as Targets for Therapeutic InterventionFIVE PRIME THERAPETUTICS INC·Filed 2004·Application pending·0 cites
- 1046US2010183620A1Compositions and methods for regulating collagen and smooth muscle actin expression by serpine2BHAWE KAUMUDI·Filed 2009·Application pending·0 cites
- 1142US2008014594A1Lung-Expressed PolypeptidesHESTIR KEVIN·Filed 2004·Application pending·0 cites
- 1241US2008112937A1Method of Producing Autologous Embryonic Stem CellsWILLIAMS LEWIS T·Filed 2005·Application pending·0 cites
- 1340US2021340214A1Cd80 extracellular domain fc fusion protein dosing regimensFIVE PRIME THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1437US2008254033A1Pharmaceutical Compositions Containing Antagonists to Lrp4, Lrp8 or Megalin for Treatment of DiseasesPIERCE KRISTEN·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kristen Pierce files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →